Sio Gene Therapies Inc.
The momentum for this stock is not very good. Sio Gene Therapies Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Sio Gene Therapies Inc..
Log in to see more information.
News
Cladis Investment Advisory LLC Has $155,000 Stake in Sio Gene Therapies Inc. (NASDAQ:SIOX)
Ticker Report Cladis Investment Advisory LLC decreased its position in shares of Sio Gene Therapies Inc. (NASDAQ:SIOX Get Rating) by 25.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 552,000 shares of the ...\n more…
Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Globe Newswire Three-Month and Nine-Month Losses decline by 84.2% and 73.5%, respectively Operating Cash Outflows for the Nine Months Ended December 31, 2022 decreased by $23.8 million or 56% versus the prior year period $46.1 million of cash and cash equivalents as of December 31, 2022, a strong cash position as ...\n more…